Bristol-Myers Squibb Co
XMUN:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
W
|
W R Berkley Corp
F:WR1
|
US |
|
Royal Bafokeng Platinum Ltd
F:7BF
|
ZA |
|
United Parcel Service Inc
NYSE:UPS
|
US |
|
Aditya Birla Lifestyle Brands Ltd
NSE:ABLBL
|
IN |
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
F
|
FL Entertainment NV
AEX:FLE
|
FR |
|
K
|
Koninklijke Philips NV
MIL:PHIA
|
NL |
|
S
|
Siemens AG
SIX:SIN
|
DE |
|
D
|
Discover Financial Services
XBER:DC7
|
US |
|
D
|
DoorDash Inc
NASDAQ:DASH
|
US |
|
M
|
Mitsubishi Chemical Group Corp
XMUN:M3C
|
JP |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BRM is 53.71 EUR with a low forecast of 28.43 EUR and a high forecast of 66.96 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
53.71
EUR
According to Wall Street analysts, the average 1-year price target for BRM is 53.71 EUR with a low forecast of 28.43 EUR and a high forecast of 66.96 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -3%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 6%.
